NEW DELHI: India is in dialogue with US biotech giant Moderna about progress in clinical trials of its coronavirus vaccine candidate, which the firm says has shown 94.5 percent efficacy, official sources said Monday. Moderna said Monday that the Data Safety Monitoring Board (DSMB) appointed by the independent National Institutes …
Read More »
HYDERABAD: Covaxin, India’s first indigenous vaccine candidate for the Covid-19 vaccine, began phase III clinical trials on Monday in what is the country’s largest human trial of a vaccine for the dreaded coronavirus. Trials began in Hyderabad with the first doses of the candidate vaccine administered to volunteers at the …
Read More »
From identifying the priority groups that will receive the COVID-19 vaccine first to organizing vaccination centers, the central government has begun to prepare a plan to implement the coronavirus vaccine in the country, once it is available. The coronavirus vaccine will be distributed under a special COVID-19 inoculation program, using …
Read More »
In good news for millions of Indians, Hyderabad-based Bharat Biotech International Ltd or BBIL announced that it will manufacture 10 types of vaccines, including malaria and novel coronavirus, at its next unit in Odisha. Attending a virtual meeting with Chief Secretary of State Asit Tripathy on Friday, BBIL President and …
Read More »
The February launch would make Bharat Biotech’s Covid vaccine the first Indian-made vaccine to be launched New Delhi: An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, …
Read More »
By: Reuters | New Delhi | Updated: November 5, 2020 3:51:40 pm Bharat Biotech developed Covaxin in collaboration with ICMR-National Institute of Virology. An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it …
Read More »
A government-backed Covid-19 vaccine could launch in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, a senior scientist told Reuters. government level. Bharat Biotech, a private company developing COVAXIN with the government-run Council of Indian …
Read More »
The rumor surrounding an impending COVID-19 vaccine has raised hopes for a path back to normal for the billions affected by the pandemic around the world, said Kiran Mazumdar-Shaw, president and managing director of Biocon Ltd. , based in Bengaluru. Mazumdar-Shaw is hoping that the vaccine will be in India …
Read More »
HYDERABAD: Bharat Biotech, which is developing Covaxin, a candidate vaccine for Covid-19, said on Friday that it has successfully completed interim analysis of phase I and II trials and is initiating phase III trials in 26,000 participants. “After successfully completing the interim analysis of Covaxin Phase 1 and 2 clinical …
Read More »
India’s Bharat Biotech is in talks with more than 10 countries that have shown interest in a possible Covid-19 vaccine it is developing with a government agency, a company executive told Reuters on Friday. The Hyderabad-based company this week received initial approval from Indian authorities to conduct late-stage trials for …
Read More »